How many COVID deaths were caused by vilifying hydroxychloroquine?
A recent study from Hackensack Meridian Health found that HCQ use in outpatient settings was associated with a reduction in hospitalization rates in symptomatic individuals with COVID-19.
Federal and state governments LIED about HCQ. Victims of malpractice should sue governors and other officials for BANNING of HCQ. Very interesting this study is released AFTER the fraudulent election.
- NY Gov Cuomo
- Nevada Govornor Sisolak
- Dr Fauci
….. the list is long and filled with Democrats and never Trumpers
when started earlier in the hospital course, for progressively longer durations and in outpatients, antimalarials may reduce the progression of disease, prevent hospitalization, and are associated with reduced mortality.
22, 23, 24 , 25
In a retrospective inpatient study of 2541 patients hospitalized with COVID-19, therapy associated with an adjusted reduction in mortality was HCQ alone (hazard ratio [HR] = 0.34, 95% confidence interval [CI] 0.25-0.46, P <0.001) and HCQ with azithromycin (HR = 0.29, 95% CI 0.22-0.40, P <0.001).23
HCQ was approved by the US Food and Drug Administration in 1955
Hat tip Orange Martyrs
New study shows hydroxychloroquine 'may be a benefit' in treating the coronavirus after all https://t.co/eZPceqdZ7q
— Charli Ann (@IrishCharli) January 30, 2021
Who stopped using hydroxychloroquine in treating Covid -19 is a killer https://t.co/n9KJe0gxCh
— Dr. Maha Atout (@mahaatout1) January 30, 2021
‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor | Sky News Australia https://t.co/2O4eXOZZp4
— Stonechlo (@SebasRotch) January 30, 2021
For months Geller Report gave our readers the facts about hydroxychloroquine – a safe drug developed in the 1930s to fight malaria. It was found to be effective early in the China virus attack.
2. HCQ works *with steroids*; these patients also receive medrol.
New study shows hydroxychloroquine ‘may be a benefit’ in treating the coronavirus after all
A medical study out of New Jersey shows the drug hydroxychloroquine may help people with mild symptoms of COVID-19.
“We make it clear we can’t recommend it to be given,” said Andrew Ip, a lymphoma physician and director of the Division of Outcomes and Value Research at the John Theurer Cancer Center. “This is only an observational study. We can only recommend it in the context of a clinical trial. There may be a benefit for using this drug in an outpatient setting.”
The study was conducted by Hackensack Meridian Health on outpatients in 2020 and found those who took hydroxychloroquine were less likely to end up in the hospital.
Ip said that more than 100 patients received the drug between March and May, and just over 1 in 5 patients landed in the hospital after the fact. Meanwhile, almost 1 in 3 of the more than 1,000 patients who did not receive the drug required hospitalization.
He added that the drug, commonly used to treat malaria, appeared to be safe.
“I’ve gotten messages from doctors saying it supports what they are seeing in their clinics,” Ip said.
The New Jersey study’s results come after a peer-reviewed study found a drug cocktail that included hydroxychloroquine lowered hospitalizations and mortality rates of coronavirus patients.
The study found that “the odds of hospitalisation of treated patients was 84% less than in the untreated patients.” Only one patient died from the group of 141 being treated with the drug cocktail, while there were 13 deaths in the untreated group of 377.
The use of hydroxychloroquine sparked controversy in 2020 when former President Donald Trump touted its use for treating the virus. Some within the medical community and the media slammed the use of the drug, and Big Tech moved to censor information championing it.
The U.S. Food and Drug Administration also reversed its emergency use authorization for hydroxychloroquine and chloroquine in June of last year.
Controversy over the drug has spilled over into 2021, with the Oklahoma attorney general’s office announcing this week it is trying to return $2 million worth of hydroxychloroquine pills after Gov. Kevin Stitt purchased the stockpile out of an abundance of caution.
“We are working with the Department of Health to try to return the stockpile,” Oklahoma Office of the Attorney General spokesman Alex Gerszewski said.
Have a tip we should know? Your anonymity is NEVER compromised. Email firstname.lastname@example.org
The Truth Must be Told
Your contribution supports independent journalism
Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.
Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.
Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.
Please contribute here.
Make a monthly commitment to support The Geller Report – choose the option that suits you best.